NORML has recently posted online the fourth edition of its popular and comprehensive booklet, “Emerging…
US News & World Report recently probed the subject of cannabis science, publishing a pair…
Investigators at the University of Mississippi report the discovery of eleven new non-cannabinoid constituents in cannabis, several of which possess “anti-microbial” (think MRSA), “anti-malarial,” and “anti-leishmanial” (a common skin parasite) activity. Scientists also reported that several of the compounds also possessed anti-inflammatory properties and acted as potent anti-oxidants.
Well what do you know? A mainstream media outlet finally picked up on this story!
Sure it’s been over a week since I first blogged about it here and here. But given the MSM’s long history of sweeping similar medi-pot revelations under the rug, this is case where I gladly say ‘better late than never.’
Several years ago, when I first began writing the booklet Emerging Clinical Applications for Cannabis and Cannabinoids, I mused about what sort of advancements in the treatment of disease may have been achieved over the past 70+ years had U.S. government chosen to advance — rather than stifle — clinical research into the therapeutic effects of cannabis.
Now, more than ever, this is a question that our elected officials — both Republican and Democrat — must answer.